New cancer drug enters first human trials
Disease control
Ongoing
This is the first study in people to test a new experimental drug called VVD-130850, which blocks a protein called STAT3 that helps cancer grow. The main goal is to find a safe dose and see how the body handles the drug, both alone and combined with an existing immunotherapy. It …
Phase: PHASE1 • Sponsor: Vividion Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC